Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Large Growth in Short Interest

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 858,900 shares, an increase of 12.1% from the November 30th total of 766,100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ? days.

Ascentage Pharma Group International Price Performance

Shares of ASPHF opened at $6.45 on Tuesday. The firm has a 50-day moving average price of $6.45 and a 200 day moving average price of $4.04. Ascentage Pharma Group International has a 12-month low of $6.45 and a 12-month high of $6.45.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.